搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Yersinia pestis bv. Antiqua UPF0227 protein YPN_2013 (YPN_2013) CSB-YP626762YAG
CSB-EP626762YAG
CSB-BP626762YAG
CSB-MP626762YAG
CSB-EP626762YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Protein dsrB (dsrB) CSB-YP626763YAG
CSB-EP626763YAG
CSB-BP626763YAG
CSB-MP626763YAG
CSB-EP626763YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Threonine--tRNA ligase (thrS), partial CSB-YP626764YAG
CSB-EP626764YAG
CSB-BP626764YAG
CSB-MP626764YAG
CSB-EP626764YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE (arnE), partial CSB-YP626765YAG1
CSB-EP626765YAG1
CSB-BP626765YAG1
CSB-MP626765YAG1
CSB-EP626765YAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Multidrug resistance protein MdtK (mdtK), partial CSB-YP626766YAG
CSB-EP626766YAG
CSB-BP626766YAG
CSB-MP626766YAG
CSB-EP626766YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Pyridoxamine kinase (pdxY) CSB-YP626767YAG
CSB-EP626767YAG
CSB-BP626767YAG
CSB-MP626767YAG
CSB-EP626767YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Electron transport complex protein RnfA (rnfA), partial CSB-YP626768YAG1
CSB-EP626768YAG1
CSB-BP626768YAG1
CSB-MP626768YAG1
CSB-EP626768YAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Tryptophan synthase beta chain (trpB) CSB-YP626769YAG
CSB-EP626769YAG
CSB-BP626769YAG
CSB-MP626769YAG
CSB-EP626769YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Spermidine export protein MdtJ (mdtJ), partial CSB-YP626770YAG1
CSB-EP626770YAG1
CSB-BP626770YAG1
CSB-MP626770YAG1
CSB-EP626770YAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua tRNA (cmo5U34)-methyltransferase (cmoA) CSB-YP626771YAG
CSB-EP626771YAG
CSB-BP626771YAG
CSB-MP626771YAG
CSB-EP626771YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Probable phosphatase YPN_1514 (YPN_1514) CSB-YP626772YAG
CSB-EP626772YAG
CSB-BP626772YAG
CSB-MP626772YAG
CSB-EP626772YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Imidazolonepropionase (hutI) CSB-YP626773YAG
CSB-EP626773YAG
CSB-BP626773YAG
CSB-MP626773YAG
CSB-EP626773YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua DNA ligase (ligA), partial CSB-YP626774YAG
CSB-EP626774YAG
CSB-BP626774YAG
CSB-MP626774YAG
CSB-EP626774YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Periplasmic nitrate reductase (napA), partial CSB-YP626775YAG
CSB-EP626775YAG
CSB-BP626775YAG
CSB-MP626775YAG
CSB-EP626775YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Putative multidrug resistance protein MdtD (mdtD), partial CSB-YP626776YAG
CSB-EP626776YAG
CSB-BP626776YAG
CSB-MP626776YAG
CSB-EP626776YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP626777YAG
CSB-EP626777YAG
CSB-BP626777YAG
CSB-MP626777YAG
CSB-EP626777YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua N-acetylmuramic acid 6-phosphate etherase (murQ) CSB-YP626778YAG
CSB-EP626778YAG
CSB-BP626778YAG
CSB-MP626778YAG
CSB-EP626778YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua UPF0249 protein YPN_1168 (YPN_1168) CSB-YP626779YAG
CSB-EP626779YAG
CSB-BP626779YAG
CSB-MP626779YAG
CSB-EP626779YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Urease subunit gamma (ureA) CSB-YP626780YAG
CSB-EP626780YAG
CSB-BP626780YAG
CSB-MP626780YAG
CSB-EP626780YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis bv. Antiqua Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP626781YAG
CSB-EP626781YAG
CSB-BP626781YAG
CSB-MP626781YAG
CSB-EP626781YAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>